APA
Turner N. C., Alarcón E., Armstrong A. C., Philco M., López Chuken Y. A., Sablin M., Tamura K., Gómez Villanueva A., Pérez-Fidalgo J. A., Cheung S. Y. A., Corcoran C., Cullberg M., Davies B. R., de Bruin E. C., Foxley A., Lindemann J. P. O., Maudsley R., Moschetta M., Outhwaite E., Pass M., Rugman P., Schiavon G. & Oliveira M. (20200612). BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Turner N C, Alarcón E, Armstrong A C, Philco M, López Chuken Y A, Sablin M-P, Tamura K, Gómez Villanueva A, Pérez-Fidalgo J A, Cheung S Y A, Corcoran C, Cullberg M, Davies B R, de Bruin E C, Foxley A, Lindemann J P O, Maudsley R, Moschetta M, Outhwaite E, Pass M, Rugman P, Schiavon G and Oliveira M. 20200612. BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Turner N. C., Alarcón E., Armstrong A. C., Philco M., López Chuken Y. A., Sablin M., Tamura K., Gómez Villanueva A., Pérez-Fidalgo J. A., Cheung S. Y. A., Corcoran C., Cullberg M., Davies B. R., de Bruin E. C., Foxley A., Lindemann J. P. O., Maudsley R., Moschetta M., Outhwaite E., Pass M., Rugman P., Schiavon G. and Oliveira M. (20200612). BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Turner N C, Alarcón E, Armstrong A C, Philco M, López Chuken Y A, Sablin M-P, Tamura K, Gómez Villanueva A, Pérez-Fidalgo J A, Cheung S Y A, Corcoran C, Cullberg M, Davies B R, de Bruin E C, Foxley A, Lindemann J P O, Maudsley R, Moschetta M, Outhwaite E, Pass M, Rugman P, Schiavon G and Oliveira M. BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population. : Annals of oncology : official journal of the European Society for Medical Oncology. 20200612.